Skip to main content

And Again

When it comes to retractions, former Duke University researcher Anil Potti is the gift that keeps on giving.

As fans of scientific malfeasance no doubt recall, Potti left Duke in 2010 amidst allegations that he had manipulated data in several lung cancer biomarker studies. Duke suspended Potti (who has since taken a job at the Cancer Center of North Dakota) along with clinical trials stemming from his research.

Potti and his colleagues also retracted a 2007 paper on these studies they published in the Journal of Clinical Oncology.

And the retractions didn't stop there. According to Retraction Watch's Ivan Oransky, there have been 10 retractions, one partial retraction, and seven corrections of Potti's research over the years. And, he writes, this month brings yet another retraction, this one of a 2008 abstract in Chest.

In his discussion of the retraction notice, Oransky highlights one particularly curious passage:

"The authors relied on the results reported by Potti, and they were not aware of the errors subsequently reported."

Of course, as Oransky notes, Potti himself was one of the authors, which raises the question of how, exactly, they could have been unaware of the questionable data underlying the work.

Maybe he just forgot to tell them? After all, if we were Potti, we probably wouldn't want to remember that stuff either.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.